Inventor · disambiguated record
Sarah Bethune
Also filed as: BETHUNE SARAH · BETHUNE SARAH J · BETHUNE SARAH JEAN
11 granted patents·3 pending applications·50 citations·filing 2010–2024
87Inventor score
Files withIMBRIA PHARMACEUTICALS INC4SCHULTHEISS NATHAN C4IKENA ONCOLOGY INC2KEROS THERAPEUTICS INC1MILLENNIUM PHARM INC1
Top patents by PatentIndex Score
14 records- 0192US8513236B2Pterostilbene cocrystalsSCHULTHEISS NATHAN C·Filed 2010·Granted Aug 20, 2013·19 cites·24 claims
- 0291US8415507B2Pterostilbene cocrystalsSCHULTHEISS NATHAN C·Filed 2010·Granted Apr 9, 2013·18 cites·23 claims
- 0388US12071438B2Crystal forms of an ALK2 inhibitorKEROS THERAPEUTICS INC·Filed 2021·Granted Aug 27, 2024·2 cites·17 claims
- 0485US8399712B2Pterostilbene cocrystalsSCHULTHEISS NATHAN C·Filed 2010·Granted Mar 19, 2013·7 cites·27 claims
- 0582US11530184B2Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·22 claims
- 0678US12065410B2Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2023·Granted Aug 20, 2024·0 cites·25 claims
- 0778US11746090B2Crystal forms of 2-[4-[(2,3,4- trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2022·Granted Sep 5, 2023·0 cites·25 claims
- 0878US8318807B2Pterostilbene cocrystalsSCHULTHEISS NATHAN C·Filed 2010·Granted Nov 27, 2012·3 cites·26 claims
- 0977US2025074878A1Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylateIMBRIA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1070US12162884B2Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a] [1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine as aryl hydrocarbon receptor (AHR) inhibitorsIKENA ONCOLOGY INC·Filed 2023·Granted Dec 10, 2024·0 cites·24 claims
- 1169US2025276975A1Polymorphic compounds and uses thereofPAHR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1266US11591339B2Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[ 1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine maleate as aryl hydrocarbon receptor (AHR) inhibitorsIKENA ONCOLOGY INC·Filed 2020·Granted Feb 28, 2023·0 cites·19 claims
- 1359US2025221997A1Tyk2 inhibitor formulations and methods of making the sameTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1453US11124519B2Cocrystal forms of ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl) methyl sulfamate, formulations and uses thereofMILLENNIUM PHARM INC·Filed 2018·Granted Sep 21, 2021·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Sarah Bethune files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →